Cat.No.:	Efna5-880M
Product Overview:	Recombinant Mouse Efna5 (Accession # NP_997537), fused with , was produced in Mouse myeloma cell line, NS0-derived.
Source:	NSO Cells
Species:	Mouse
Tag:	Fc
Predicted N Terminal:	No results obtained: Gln21 predicted, sequencing might be blocked
Form:	Lyophilized from a 0.2 µm filtered solution in PBS.
Bio-activity:	Measured by its ability to inhibit proliferation of PC-3 human prostate cancer cells.The ED50 for this effect is typically 2.5-10 ng/mL.
Molecular Mass:	Recombinant Mouse Efna5, Fc Chimera has a calculated MW of 48.4 kDa (monomer). In SDS-PAGE migrates as 57-60 kDa, reducing conditions.
Purity:	>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Storage:	Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Reconstitution:	Reconstitute at 100 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.

Gene Name:	Efna5 ephrin A5 [ Mus musculus ]
Official Symbol:	Efna5
Synonyms:	EFNA5; ephrin A5; ephrin-A5; EPH-related receptor tyrosine kinase ligand 7; AL-1; Epl7; RAGS; EFL-5; LERK-7; AV158822; Ephrin-A5;
Gene ID:	13640
mRNA Refseq:	NM_010109
Protein Refseq:	NP_034239
MIM:

Online Inquiry